Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MOBERG PHARMA AB
No Price
Closing Price XSTO 30.04.2026:
11,50 SEK
30.04.2026 17:31
Current Prices from MOBERG PHARMA AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Düsseldorf
MPABAA28.DUSB
EUR
30.04.2026 17:31
1,06 EUR
-
NASDAQ STOCKHOLM AB
MOB.ST
SEK
30.04.2026 10:59
11,50 SEK
-
Quotrix
MPABAA28.DUSD
EUR
30.04.2026 07:42
1,05 EUR
-
Share Float & Liquidity
Free Float85,96 %
Shares Float40,4 M
Shares Outstanding47 M
Company Profile for MOBERG PHARMA AB Share
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
